Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Long-Term Investments (2023 - 2026)

BioAge Labs' Long-Term Investments history spans 3 years, with the latest figure at $100000.0 for Q4 2025.

  • On a quarterly basis, Long-Term Investments changed 0.0% to $100000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $100000.0, a 0.0% change, with the full-year FY2025 number at $100000.0, changed 0.0% from a year prior.
  • Long-Term Investments hit $100000.0 in Q4 2025 for BioAge Labs, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for BIOA hit a ceiling of $100000.0 in Q4 2023 and a floor of $100000.0 in Q4 2023.
  • Historically, Long-Term Investments has averaged $100000.0 across 3 years, with a median of $100000.0 in 2023.
  • The widest YoY moves for Long-Term Investments: up 0.0% in 2024, down 0.0% in 2024.
  • Tracing BIOA's Long-Term Investments over 3 years: stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Business Quant data shows Long-Term Investments for BIOA at $100000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.